Law360
Expect Aggressive Healthcare Scrutiny From Mass. US Atty
March 30, 2021
It has now been nearly two months since President Joe Biden's inauguration. The transition to a new U.S. attorney in the District of Massachusetts is in full swing, and we can expect a new, presidentially appointed U.S. attorney later this year. Yet, even though this represents a time of transition for the U.S. Attorney's Office, we expect that the office will continue to make civil and criminal healthcare enforcement a priority.
Contacts
Offices
Related Resources
Capabilities
Suggested News & Insights
U.S. Drug Pricing Year in Review: Reflections on 2025 and Getting Ready for 2026December 11, 2025What the U.S.–UK Drug Pricing Agreement Reveals About How MFN Drug Policy Could Impact the UK and EUDecember 10, 2025Sidley Represents Lumexa Imaging in US$462.5 Million Initial Public OfferingDecember 10, 2025First Circuit Clarifies Application of Medicare’s “Reasonable and Necessary” Standard in FCA Cases Against Clinical LabsDecember 8, 2025Medicare Payment Policy Final Rule for Outpatient Setting Addresses Radiopharmaceuticals, Skin Substitutes, and 340B Program Key TopicsDecember 2, 2025#DrugPricing: Average Sales Price (ASP) Calculation in FocusThursday, November 20, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

